Microbial Etiology of Travelers' Diarrhea in Mexico, Guatemala, and India: Importance of Enterotoxigenic Bacteroides fragilis and Arcobacter Species-Reference-Cited by-同舟云学术

Microbial Etiology of Travelers' Diarrhea in Mexico, Guatemala, and India: Importance of Enterotoxigenic Bacteroides fragilis and Arcobacter Species

Published:2010-04 Issue:4 Volume:48 Page:1417-1419
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Jiang Zhi-Dong¹,DuPont Herbert L.¹²³⁴,Brown Eric L.¹,Nandy Ranjan K.⁵,Ramamurthy Thandavaryan⁵,Sinha Anuradha⁵,Ghosh Santanu⁵,Guin Sucharita⁵,Gurleen Kaur⁶,Rodrigues Savio⁶,Chen Jacklyn J.²,McKenzie Robin⁷,Steffen Robert⁸

Affiliation:

1. The University of Texas School of Public Health

2. the University of Texas Medical School at Houston

3. Baylor College of Medicine

4. St. Luke's Episcopal Hospital, Houston, Texas

5. National Institute of Cholera and Enteric Diseases, Kolkata, India

6. Goa Medical College, Bambolim Goa, India

7. Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

8. Institute of Social and Preventive Medicine of the University of Zurich, Zurich, Switzerland

Abstract

ABSTRACT This study examined established enteric pathogens, Arcobacter species and enterotoxigenic Bacteroides fragilis (ETBF), in 201 U.S. and European travelers with acute diarrhea acquired in Mexico, Guatemala, and India. Arcobacter butzleri and ETBF were detected in 8% and 7% of diarrhea cases, respectively.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.01709-09

Reference25 articles.

1. Burnens, A. P., P. Boss, F. Orskov, I. Orskov, U. B. Schaad, F. Muller, R. Heinzle, and J. Nicolet. 1992. Occurrence and phenotypic properties of verotoxin producing Escherichia coli in sporadic cases of gastroenteritis. Eur. J. Clin. Microbiol. Infect. Dis. 11 : 631-634.

2. DuPont, H. L., C. D. Ericsson, J. J. Mathewson, F. J. de la Cabada, and D. A. Conrad. 1992. Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico. JAMA 267 : 1932-1935.

3. Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study

4. DuPont, H. L., R. Haake, D. N. Taylor, C. D. Ericsson, Z. D. Jiang, P. C. Okhuysen, and R. Steffen. 2007. Rifaximin treatment of pathogen-negative travelers' diarrhea. J. Travel Med. 14 : 16-19.

5. Dupont, H. L., Z. D. Jiang, J. Belkind-Gerson, P. C. Okhuysen, C. D. Ericsson, S. Ke, D. B. Huang, M. W. Dupont, J. A. Adachi, F. J. De La Cabada, D. N. Taylor, S. Jaini, and F. Martinez Sandoval. 2007. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin. Gastroenterol. Hepatol. 5 : 451-456.

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Removal of bacterial pathogens and antibiotic resistance bacteria by anaerobic sludge digestion with thermal hydrolysis pre-treatment and alkaline stabilization post-treatment;Chemosphere;2023-02

2. Evaluation of the Modulatory Effects of Antibiotic-Resistant Lactobacillus Plantarum Atcc14917 on the Antibiotic-Disturbed Intestinal Microbiota Using a Mice Model;2023

3. Arcobacter;Reference Module in Food Science;2023

4. Colonization with extended-spectrum beta-lactamase-producing Escherichia coli and traveler’s diarrhea attack rates among travelers to India: a systematic review and meta-analysis;Tropical Diseases, Travel Medicine and Vaccines;2022-10-01

5. Prevalence and Antibiotic Resistance of Arcobacter spp. Isolates from Meats, Meat Products, and Giblets;Acta Veterinaria Eurasia;2022-06-07